People

Aerovate Therapeutics has announced that former Proteon Therapeutics President and CEO Timothy Noyes has been named CEO and elected to the company’s board of directors. Noyes was most recently CEO of Arcuate Therapeutics, and he… Read more . . .

Connected nebulizer maker AireHealth has announced the appointment of Kien Nguyen as its new CEO and as a member of its board. Nguyen was most recently Chief Commercial Officer at Progenerative Medical. In December 2020,… Read more . . .

Impel NeuroPharma has named Leonard S. Paolillo as Chief Commercial Officer and Gerald F. Penn as VP, Market Access and Trade in anticipation of the launch of Trudhesa intranasal dihydroergotamine mesylate (DHE) for the treatment… Read more . . .

Dutch DPI developer PureIMS has announced the appointment of Bram van Dijck as its new Chief Executive Officer, succeeding Reinier Schwietert, who is stepping down as CEO but will remain with the company. Van Dijck was… Read more . . .

According to Proveris Scientific, Lynn Jordan has joined the company as Applications Laboratory Manager. Proveris offers laboratory services for development and analysis of a wide range of OINDPs, and the company launched new cGMP compliant… Read more . . .

Inhalation CDMO Vectura has announced the resignation of Aerami CEO Anne Whitaker from Vectura’s board of directors “in light of potential conflicts that could arise in the future as a result of her role of… Read more . . .

Inhaled drug developer Savara has announced the departures of its co-founders, CEO Rob Neville and President and Chief Business Officer Taneli Jouhikainen, who have resigned “to pursue other opportunities,” according to the company. Matthew Pauls, who… Read more . . .

Finnish nanonization specialist Nanoform has announced the appointments of Eric Peter and Sergie Letser to the company’s US business development team. In January 2020, Nanoform announced the appointment of Sally Langa as its new Head of… Read more . . .

Inhaled drug company MannKind Corporation has announced the appointment of Kevin Kaiserman as VP, Medical Affairs and Safety. Kaiserman, a pedicatric endocrinologist, was most recently in private practice. The company markets Afrezza inhaled insulin, which was… Read more . . .